Skip to content

Supporting Treatment Adherence Needs in Diabetes

Supporting Treatment Adherence Needs in Diabetes: The STAND Study

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01030471
Acronym
STAND
Enrollment
0
Registered
2009-12-11
Start date
2009-09-30
Completion date
2012-09-30
Last updated
2020-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 Diabetes

Keywords

adolescents, depression, adherence, family functioning, intervention

Brief summary

There is an unmet treatment need for depressed adolescents with type 1 diabetes. To address this unmet need, we have designed a new, family-based, cognitive-behavioral intervention to reduce depressive symptoms, improve family functioning, and improve medication compliance. The intervention is delivered in two phases (1 - reduction of depressive symptoms and family conflict, 2 - adherence promotion) as efforts to improve adherence will have a greater likelihood of success if individual and family functioning variables are addressed first. To test the effectiveness of this intervention in reducing depressive symptoms and improving adherence, we will conduct a randomized controlled trial comparing this new intervention to usual care in a sample of fifty-two adolescents with type 1 diabetes and their primary caregivers. Given the absence of this type of intervention and the significance of the problem, this study is timely and important, as it has the potential to positively impact diabetes-specific health outcomes.

Interventions

BEHAVIORALFamily-based cognitive-behavioral treatment

Participants will engage in ten weekly sessions aimed at improving depressive symptoms and medication compliance via reducing family conflict and improving communication among family members.

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
Children's Hospital Medical Center, Cincinnati
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
13 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* Age 13-17 * Diagnosis of type 1 diabetes according to criteria from the ADA for at least 1 year * Daily insulin dosing of at least 0.5 units per kilogram per day * Clinical elevation on the CDI (i.e., score at or above 13) * Assent to participation in study

Exclusion criteria

* Other chronic, physical disease or condition except for celiac or thyroid disease * Diagnosis of major mental disorder (e.g., bipolar disorder, thought disorder, anorexia nervosa) * Diagnosis of developmental disorder (e.g., mental retardation, autism, Asperger's) * Current enrollment in psychotherapy specifically targeting depression

Design outcomes

Primary

MeasureTime frame
Children's Depression Inventory (CDI)-Measure of adolescent depressive symptomsAssessed at 0, 1.5, 3, and 6 months after enrollment
Diabetes-Related Family Conflict Scale (DFCS)-Measure of family conflict around diabetes-specific tasksAssessed at 0, 1.5, 3, and 6 months from enrollment

Secondary

MeasureTime frame
Hemoglobin A1c valueObtained at 0, 3, and 6 months after enrollment

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026